Synopsis of recent research by authors named "Dilia Giuggioli"
- Dilia Giuggioli's recent research focuses on systemic sclerosis (SSc) and its complications, particularly exploring cardiovascular risk factors, treatment efficacy, and the impact of comorbidities on patient outcomes.
- Significant findings include the prognostic value of the TAPSE/sPAP ratio in SSc patients with pulmonary hypertension, as well as insights into the retention rates of therapies such as mycophenolate mofetil and rituximab over the long term.
- Giuggioli's studies involve a mix of observational studies, clinical practice assessments, and meta-analyses, highlighting the importance of both pharmacological approaches and non-invasive diagnostic tools in managing complex cases of SSc.
